Home / News / India News / Article /
Dr Reddy's launches generic cancer injection in US
Updated On: 26 December, 2017 04:57 PM IST | New Delhi | PTI
Pharma major Dr Reddy's Laboratories today said it has launched a generic version of Melphalan Hydrochloride for injection, used in the treatment of cancer, in the US. The launch follows approval of Melphalan Hydrochloride for Injection
Listen to this article :

Pharma major Dr Reddy's Laboratories today said it has launched a generic version of Melphalan Hydrochloride for injection, used in the treatment of cancer, in the US. The launch follows approval of Melphalan Hydrochloride for Injection, a therapeutic equivalent generic version of Alkeran marketed by Apotex Inc, by the US Food and Drug Administration (USFDA), it said in a statement.

Representational Image


